Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Mostrar otras versiones (1)

Hydroxychloroquine has been promoted for its use in treatment of COVID-19 patients based on in-vitro evidences. We searched the databases to include randomized and observational studies evaluating the effect of Hydroxychloroquine on mortality in COVID-19 patients. The outcome was summarized as odds...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Tejas K., Barvaliya, Manish, Kevadiya, Bhavesh D., Patel, Parvati B., Bhalla, Hira Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280684/
https://www.ncbi.nlm.nih.gov/pubmed/32519281
http://dx.doi.org/10.1007/s11481-020-09930-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280684/
https://www.ncbi.nlm.nih.gov/pubmed/32519281
http://dx.doi.org/10.1007/s11481-020-09930-x

Ejemplares similares